Morgans Senior Analyst Scott Power recaps the healthcare picks for and what to look out for across the current active opportunities.
Some of the companies Scott talks about are: Mach7 Technologies (ASX:M7T), Impedimed (ASX:IPD), Micro-X(ASX:MX1), and Neuron Pharmaceuticals (ASX:NEU).